Table 1.
Summary of the preanalytical variable assessments in this study
Parameter | Factor | Outcome∗ |
---|---|---|
Circadian rhythm (Fig. 1A) |
|
|
Anticoagulant (Fig. 1B) (EDTA used as reference) |
|
|
|
|
|
Tube parameters (Fig. 1C; Fig. 1D) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Whole blood stability in EDTA tube (Fig. 2A) |
|
|
| ||
| ||
EDTA plasma storage after thawing (Fig. 2B) |
|
|
|
|
|
Fresh EDTA plasma storage (Fig. 2C) |
|
|
Number of tube transfers (Fig. 3A) |
|
|
Effect of the collection tube on stability during freezing (Fig. 3B) |
|
|
|
|
|
|
|
|
|
|
|
Freeze/thaw cycles (–80°C) (Fig. 3C) |
|
|
Freeze/thaw cycles (–25°C) (Fig. 3D) |
|
|
Freeze/thaw cycles (–20°C) (Fig. 3D) |
|
|
Abbreviations: Aβ, amyloid β; EDTA, ethylenediaminetetraacetic acid; Li-heparin, lithium heparin; PET, polyethylene terephthalate; PP, polypropylene; RT, room temperature; tTau, total Tau.
Outcomes listed apply to all peptide measures unless otherwise indicated.
Only Aβ(1-40) and Aβ(1-42) and Aβ(1-42): Aβ(1-40) assessed; tTau not evaluated due to the high stability of tTau in thawed plasma.